tirzepatide attenuates mammary tumor progression in diet induced obese mice E0771 BC growth is accelerated female fed a 60% HFD. A International Journal of Oncology

The STEP 1 clinical trial showed participants on 2.4 mg semaglutide lost an average of 14.9% of body weight over 68 weeks

While compounded tirzepatide is not FDA-approved, our preferred pharmacy provider adheres to all relevant federal and state regulations and FDA guidelines.* Other medication treatment options: Ozempic (semaglutide): Ozempic comes in a once-weekly injectable format

Participants who tolerated 10 mg but did not tolerate 15 mg continued on 10 mg as their maximum tolerated dose

Because your journey is personal and your medication should be too

licensed doctors who guide treatments with intention, expertise, and ongoing support

Where else do you ship aside from the United States